|
1
|
Thomson JA, Itskovitz-Eldor J, Shapiro SS,
et al: Embryonic stem cell lines derived from human blastocysts.
Science. 282:1145–1147. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Irion S, Nostro MC, Kattman SJ and Keller
GM: Directed differentiation of pluripotent stem cells: from
developmental biology to therapeutic applications. Cold Spring Harb
Symp Quant Biol. 73:101–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murry CE and Keller G: Differentiation of
embryonic stem cells to clinically relevant populations: lessons
from embryonic development. Cell. 132:661–680. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murry CE, Reinecke H and Pabon LM:
Regeneration gaps: observations on stem cells and cardiac repair. J
Am Coll Cardiol. 47:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Freund C and Mummery CL: Prospects for
pluripotent stem cell-derived cardiomyocytes in cardiac cell
therapy and as disease models. J Cell Biochem. 107:592–599. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Avery S, Zafarana G, Gokhale PJ and
Andrews PW: The role of SMAD4 in human embryonic stem cell
self-renewal and stem cell fate. Stem Cells. 28:863–873.
2010.PubMed/NCBI
|
|
7
|
Poon E, Clermont F, Firpo MT and Akhurst
RJ: TGFbeta inhibition of yolk-sac-like differentiation of human
embryonic stem-cell-derived embryoid bodies illustrates differences
between early mouse and human development. J Cell Sci. 119:759–768.
2006. View Article : Google Scholar
|
|
8
|
Massagué J and Wotton D: Transcriptional
control by the TGF-beta/Smad signaling system. EMBO J.
19:1745–1754. 2000.PubMed/NCBI
|
|
9
|
Doetschman T, Shull M, Kier A and Coffin
JD: Embryonic stem cell model systems for vascular morphogenesis
and cardiac disorders. Hypertension. 22:618–629. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shull MM, Ormsby I, Kier AB, et al:
Targeted disruption of the mouse transforming growth factor-beta 1
gene results in multifocal inflammatory disease. Nature.
359:693–699. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oshima M, Oshima H and Taketo MM: TGF-beta
receptor type II deficiency results in defects of yolk sac
hematopoiesis and vasculogenesis. Dev Biol. 179:297–302. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vallier L, Alexander M and Pedersen RA:
Activin/Nodal and FGF pathways cooperate to maintain pluripotency
of human embryonic stem cells. J Cell Sci. 118:4495–4509. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Besser D: Expression of nodal, lefty-a,
and lefty-B in undifferentiated human embryonic stem cells requires
activation of Smad2/3. J Biol Chem. 279:45076–45084. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
James D, Levine AJ, Besser D and
Hemmati-Brivanlou A: TGFbeta/activin/nodal signaling is necessary
for the maintenance of pluripotency in human embryonic stem cells.
Development. 132:1273–1282. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ng YS, Ramsauer M, Loureiro RM and D’Amore
PA: Identification of genes involved in VEGF-mediated vascular
morphogenesis using embryonic stem cell-derived cystic embryoid
bodies. Lab Invest. 84:1209–1218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gendron RL, Tsai FY, Paradis H and Arceci
RJ: Induction of embryonic vasculogenesis by bFGF and LIF in vitro
and in vivo. Dev Biol. 177:332–346. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirashima M, Kataoka H, Nishikawa S, et
al: Maturation of embryonic stem cells into endothelial cells in an
in vitro model of vasculogenesis. Blood. 93:1253–1263.
1999.PubMed/NCBI
|
|
18
|
Goumans MJ, Zwijsen A, van Rooijen MA, et
al: Transforming growth factor-beta signalling in extraembryonic
mesoderm is required for yolk sac vasculogenesis in mice.
Development. 126:3473–3483. 1999.PubMed/NCBI
|
|
19
|
Zhang XJ, Tsung HC, Caen JP, Li XL, Yao Z
and Han ZC: Vasculogenesis from embryonic bodies of murine
embryonic stem cells transfected by Tgf-beta1 gene. Endothelium.
6:95–106. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang WJ and Cao YL: Stem cell, the basis
for tissue and organ reconstruction. Zhongguo Yi Xue Ke Xue Yuan
Xue Bao. 27:662–664. 2005.(In Chinese).
|
|
21
|
Wu CF, Tsung HC, Zhang WJ, et al: Improved
cryopreservation of human embryonic stem cells with trehalose.
Reprod Biomed Online. 11:733–739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wall RT, Counts RB, Harker LA and Striker
GE: Binding and release of factor VIII/von Willebrand’s factor by
human endothelial cells. Br J Haematol. 46:287–298. 1980.
|
|
23
|
Dahéron L, Opitz SL, Zaehres H, et al:
LIF/STAT3 signaling fails to maintain self-renewal of human
embryonic stem cells. Stem Cells. 22:770–778. 2004.PubMed/NCBI
|
|
24
|
Bendall SC, Stewart MH, Menendez P, et al:
IGF and FGF cooperatively establish the regulatory stem cell niche
of pluripotent human cells in vitro. Nature. 448:1015–1021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JS, Seo TW, Yi JH, et al: CHIP has a
protective role against oxidative stress-induced cell death through
specific regulation of endonuclease G. Cell Death Dis. 4:e6662013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibuya M: Tyrosine kinase receptor
Flt/VEGFR family: Its characterization related to angiogenesis and
cancer. Genes Cancer. 1:1119–1123. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jeon SH, Chae BC, Kim HA, et al:
Mechanisms underlying TGF-beta1-induced expression of VEGF and
Flk-1 in mouse macrophages and their implications for angiogenesis.
J Leukoc Biol. 81:557–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leibovich SJ and Wiseman DM: Macrophages,
wound repair and angiogenesis. Prog Clin Biol Res. 266:131–145.
1988.PubMed/NCBI
|
|
29
|
Park C, Kim TM and Malik AB:
Transcriptional regulation of endothelial cell and vascular
development. Circ Res. 112:1380–1400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roberts AB, Sporn MB, Assoian RK, et al:
Transforming growth factor type beta: rapid induction of fibrosis
and angiogenesis in vivo and stimulation of collagen formation in
vitro. Proc Natl Acad Sci USA. 83:4167–4171. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carmeliet P, Ferreira V, Breier G, et al:
Abnormal blood vessel development and lethality in embryos lacking
a single VEGF allele. Nature. 380:435–439. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baird A and Durkin T: Inhibition of
endothelial cell proliferation by type beta-transforming growth
factor: interactions with acidic and basic fibroblast growth
factors. Biochem Biophys Res Commun. 138:476–482. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heimark RL, Twardzik DR and Schwartz SM:
Inhibition of endothelial regeneration by type-beta transforming
growth factor from platelets. Science. 233:1078–1080. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maharaj AS, Saint-Geniez M, Maldonado AE
and D’Amore PA: Vascular endothelial growth factor localization in
the adult. Am J Pathol. 168:639–648. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ferrara N and Bunting S: Vascular
endothelial growth factor, a specific regulator of angiogenesis.
Curr Opin Nephrol Hypertens. 5:35–44. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ingber DE, Madri JA and Jamieson JD: Role
of basal lamina in neoplastic disorganization of tissue
architecture. Proc Natl Acad Sci USA. 78:3901–3905. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Merwin JR, Anderson JM, Kocher O, Van
Itallie CM and Madri JA: Transforming growth factor beta 1
modulates extracellular matrix organization and cell-cell
junctional complex formation during in vitro angiogenesis. J Cell
Physiol. 142:117–128. 1990. View Article : Google Scholar
|
|
38
|
Cavallaro U, Liebner S and Dejana E:
Endothelial cadherins and tumor angiogenesis. Exp Cell Res.
312:659–667. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lammert E and Axnick J: Vascular lumen
formation. Cold Spring Harb Perspect Med. 2:a0066192012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lampugnani MG, Orsenigo F, Rudini N, et
al: CCM1 regulates vascular-lumen organization by inducing
endothelial polarity. J Cell Sci. 123:1073–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Strilić B, Kucera T, Eglinger J, et al:
The molecular basis of vascular lumen formation in the developing
mouse aorta. Dev Cell. 17:505–515. 2009.PubMed/NCBI
|
|
42
|
Cook BD, Ferrari G, Pintucci G and
Mignatti P: TGF-beta1 induces rearrangement of
FLK-1-VE-cadherin-beta-catenin complex at the adherens junction
through VEGF-mediated signaling. J Cell Biochem. 105:1367–1373.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mignone JL, Kreutziger KL, Paige SL and
Murry CE: Cardiogenesis from human embryonic stem cells. Circ J.
74:2517–2526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Goumans MJ, de Boer TP, Smits AM, et al:
TGF-beta1 induces efficient differentiation of human cardiomyocyte
progenitor cells into functional cardiomyocytes in vitro. Stem Cell
Res. 1:138–149. 2007. View Article : Google Scholar : PubMed/NCBI
|
